At some point during residency or fellowship, every ophthalmologist runs the mental math on starting their own practice. The appeal writes itself: full control, full ownership, no politics, no one else's systems or culture or baggage. You design it exactly the way you want and build something that belongs entirely to you.
Then you look at the actual numbers, and the picture changes.
Building an ophthalmology practice from scratch is one of the most capital-intensive and time-consuming paths available to a physician coming out of training. The startup costs are steep, the timeline to profitability is long, and the operational burden during those early months falls squarely on the person who is also supposed to be building a surgical career. Most physicians underestimate all 3 because their training prepared them for clinical excellence, not business formation. And that gap between expectation and reality is where the trouble starts.
Buying into an existing practice sidesteps most of those problems before they begin.
What It Actually Costs to Start From Zero
Opening an ophthalmology practice means securing a physical location, negotiating and building out the space, purchasing or leasing diagnostic and surgical equipment, implementing an EHR, building a billing operation, hiring and training a clinical team, and getting credentialed with every insurance payer you intend to bill. None of these steps are optional and none of them happen quickly.
A fully equipped ophthalmology suite with diagnostic imaging, laser systems, and a minor procedure room can easily require $500,000 to $1M in capital before the 1st patient walks through the door. Lease negotiation and tenant improvement timelines can push the opening date out by 6 months or more. Insurance credentialing alone, the process that allows the practice to bill commercially, takes 3 to 6 months per payer, and until those contracts are in place, the practice is functionally unable to generate most of its expected revenue.
During the entire ramp period, the physician is paying rent on a space, paying staff who aren't yet fully utilized, servicing equipment leases, and watching the bank account move in one direction. Most estimates put the timeline to positive cash flow for a new ophthalmology practice at 18 to 36 months. That's a long time to subsidize a business out of personal savings or debt while simultaneously trying to build a clinical reputation.
What an Existing Practice Gives You From Day One
The reason buying into an established practice changes the math so dramatically is that every one of those startup problems has already been solved by someone else over the course of decades.
Patients are already there. The practice has an active patient base with scheduled follow-ups, established recall systems, and a community reputation that drives new patients through the door without advertising. A solo ophthalmologist who has practiced in the same location for 25 years has relationships with thousands of patients, many of whom have been coming back annually for chronic conditions like glaucoma and macular degeneration. A successor physician inherits that patient volume on day one. There's no waiting for the phone to ring, no marketing spend hoping to generate awareness, and no slow months wondering whether the practice will survive long enough to reach scale.
Staff is already trained and operational. The front desk knows the scheduling system and the patient flow. The technicians know the equipment and the physician's preferences. The surgical coordinator manages the ASC relationships and the referral logistics. The billing team knows the payer contracts and the coding patterns. Walking into that team is fundamentally different from hiring strangers, training them from scratch, enduring the inevitable early turnover, and spending the 1st year troubleshooting operational problems that an established practice solved a decade ago.
Equipment is already in place, maintained, and functional. The slit lamps, the OCT, the visual field analyzers, and the lasers are calibrated, under maintenance contracts, and ready for clinical use. A startup requires sourcing every piece individually, negotiating pricing without volume leverage, coordinating delivery and installation timelines, and absorbing the capital hit all at once.
Credentialing is already done at the practice level. The practice is in-network with every relevant commercial and government payer. The successor physician still needs to complete individual credentialing, but the practice-level contracts are active and billing can continue during the transition. Compare that to a startup where the practice itself has no payer relationships and the physician can't bill commercially until each contract is individually negotiated and approved.
Referral networks are already established and producing. Optometrists in the area know the practice and send patients there. Primary care physicians have been referring to that address for years. Other specialists in the community have working relationships with the clinical team. These networks took decades to build and they can't be replicated by a new practice in months. A new physician in a new location with no referral relationships is starting from zero in a market where trust is earned slowly and switched reluctantly.
The Real Cost Is Time
The variable that physicians most frequently undervalue in this calculation is time.
A physician who buys into an existing practice can see a full schedule of patients within the 1st month, generate meaningful revenue within the 1st week, and operate at or near full capacity within 90 days. The adjustment period is about clinical integration, learning the team, learning the patient base, and building relationships with the staff, not about whether the business will survive.
A physician who builds from scratch spends the 1st 6 to 9 months on logistics that have nothing to do with patient care: negotiating the lease, managing the build-out, selecting and purchasing equipment, interviewing and hiring staff, configuring the EHR, getting credentialed, setting up the billing system, and figuring out marketing. Clinical work starts later, and the patient volume builds slowly from a standing start.
Every month spent on business formation during the early years of a career is a month not spent building surgical volume, developing subspecialty expertise, and establishing the clinical reputation that will define the next 3 decades. For a young ophthalmologist, those months compound in ways that are easy to dismiss in the moment and difficult to recover later.
The Control Tradeoff
The strongest argument for building from scratch has always been control. The physician chooses everything: the location, the staff, the systems, the culture, the equipment, the workflow. There's no one else's legacy to inherit or work around. You start clean.
That preference is legitimate and worth taking seriously, but it's also worth separating the desire for control from the practical requirement for it.
In a well-structured buy-in arrangement, the successor physician retains full clinical autonomy. Every clinical decision, every treatment plan, and every surgical judgment remains with the physician. What gets handed off to the management side is the work that most physicians didn't go to medical school to do: payroll, vendor negotiations, lease management, compliance reporting, marketing, HR, and the dozens of other operational tasks that consume hours every week without contributing to patient care.
The real question isn't whether you want control, it's what you want control over. If the answer is clinical care, patient outcomes, and your own surgical development, a buy-in gives you more of that, not less, because someone else is handling everything that would otherwise eat your time.
The Risk Comparison
Building from scratch concentrates every category of risk on one person. The physician is the sole investor, the sole operator, the sole revenue generator, and the sole decision-maker. If the ramp takes longer than projected, the physician absorbs the loss. If a key hire leaves during the startup phase, operations stall. If credentialing with a major payer gets delayed, revenue projections shift by months and the financial model breaks.
Buying into an existing practice distributes that risk across a foundation that already works. The patient base provides revenue stability from day one, the trained staff provides operational continuity, and the payer contracts are active and producing. The physician is stepping into a system where the business risk has already been substantially de-risked by decades of operation.
That doesn't mean the buy-in path is risk-free. Due diligence still matters, and the terms of the arrangement need to protect the physician. But the baseline risk of a functioning practice with real patients, real staff, and real revenue is a different category entirely from the baseline risk of an empty suite and a business plan.
Why This Matters Right Now in Ophthalmology
Ophthalmology has specific characteristics that make the buy-in path especially compelling. The specialty requires expensive diagnostic and surgical equipment with high upfront costs. Insurance credentialing is complex, slow, and varies significantly by state. Patient relationships span decades because the most common conditions, including glaucoma, macular degeneration, diabetic retinopathy, and cataracts, require ongoing monitoring and repeated intervention over the course of a patient's life. And the referral networks that drive patient volume are built on years of personal relationships between optometrists, primary care physicians, and the ophthalmology practice.
Every one of those factors increases the cost and time required to build from scratch, and every one of them increases the value of stepping into a practice where those assets already exist.
With thousands of solo ophthalmologists approaching retirement age over the next decade and a well-documented shortage of new physicians entering independent practice, the number of established practices available for buy-in is growing. The physicians who position themselves early, who start exploring successor roles before the best opportunities are taken, will have more options and better terms than those who wait until the market has already thinned out.
The window is open, and it won't stay open indefinitely.
This article is for general educational purposes and is not legal or financial advice.
Verdira is a healthcare acquisition platform focused on ophthalmology practices, built around physician ownership, transparent structure, and no volume quotas. If you're a physician exploring ownership and want to understand what a successor role looks like, we're open to thoughtful conversations.
Contact info@verdira.com | 307-381-3734 | verdira.com
